Clinical application of comprehensive chromosomal screening at the blastocyst stage
To access this article, please choose from the options below
W.S. has nothing to disclose. E.F. has nothing to disclose. J.S. has nothing to disclose. S.M. has nothing to disclose. M.K.-J. has nothing to disclose. D.W. has nothing to disclose.
The first two authors contributed equally to this work.
Dr. Wells was funded by the NIHR Biomedical Research Centre Programme.
PII: S0015-0282(09)03875-8
doi:10.1016/j.fertnstert.2009.10.015
© 2010 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.

